Stem Cell Research Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stem Cell Research

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Shawn Donahue	4/26/2005 3:16:00 PM
	of 495

2nd Stem Cell Operation Planned for Patient Hwang By Kim Tae-gyu Staff Reporter A second round of stem cell therapy will be conducted on a woman who walked again last year after being paralyzed for 19 years via a first-round operation. According to Hanyang University medical team led by professor Kim Jae-min, spinal cord patient Hwang Mi-soon was hospitalized on Monday for stem cell therapy late this week. ``After medical tests, we plan to carry out an operation on Hwang as early as this Thursday. The date may be delayed to next week if tests take longer than expected, though,¡¯¡¯ Kim said. Kim¡¯s team will transplant stem cells harvested from a tiny amount of blood retrieved from the vein of an umbilical cord after the delivery of a baby, in Hwang¡¯s spine. Late last October, Hwang caught the world by surprise as she took a few steps for reporters in Seoul with the aid of a walker roughly a month after doctors injected cord blood stem cells in her spine. It was called a miracle because Hwang had been bedridden for the past 19 years since her lower limbs were paralyzed due to a back injury in 1985. ``Even though the development pace has slowed down, I feel my spine keeps improving. Now I can raise my feet myself to an extent that people can recognize it,¡¯¡¯ Hwang said. The 38-year-old hopes she will be able to walk without the help of a walker after the second operation. Kim explained that Hwang¡¯s narrow spine tube hinders continual improvement because the differentiated neuron cells cannot move through the stuffed pathway. ``This time around, we will broaden the pathway of her spine and inject umbilical cord blood at the spot so that it can differentiate and go further down via the spine,¡¯¡¯ Kim said. But he cautioned against any hasty celebration on Hwang¡¯s case as nobody can predict the result of the unprecedented operation. ``We believe this clinical test will be safe. But nobody can secure 100 percent safety in the long term and we should be cautious in making any predictions,¡¯¡¯ Kim said. times.hankooki.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next